Licensing Case Study

Targeted Therapy program for Solid pulmonary tumors

Conducted market research to identify gaps and opportunities in the pulmonary tumor market

Identified blood cancers and glioblastoma as secondary opportunity for the mechanism

  • Primary inputs from licensing community supported hematological tumors and glioblastoma as better opportunities for the program
  • Market research helped re position the program with better opportunities of licensing

 

Licensing opportunity

Oncology targeted therapy program with unique mechanism of action

Primary inputs from licensing community advised completion of Phase II

Brought term sheets for alternate markets as a means to fund the clinical trials

Strategy allowed keeping the primary market secure for licensing and progressing the program